UnitedHealth shares plummet 16% due to DOJ fraud investigation, company facing challenges

From Quiver Quantitative LLC: 2025-05-15 23:02:00

UnitedHealth Group’s shares dropped 16% to a five-year low following reports of a DOJ investigation into potential Medicare fraud. CEO Andrew Witty’s resignation and the suspension of annual guidance added to investor anxiety, with UNH experiencing its worst two-day performance on the S&P 500. Peers CVS, Centene, Elevance, and Humana also saw declines. Analysts are closely watching for details on the inquiry and UnitedHealth’s ability to stabilize operations amidst ongoing challenges.

Despite recent setbacks, some analysts believe in UnitedHealth’s core business strength and see the stock decline as a potential buying opportunity for long-term investors. The DOJ investigation, leadership changes, and market uncertainty continue to weigh on the company’s performance and market confidence, with significant erosion in market cap. The company’s response to the probe and ability to restore investor trust will be key factors in future performance.



Read more at Quiver Quantitative LLC: UnitedHealth (UNH) Faces DOJ Probe, Shares Dive 16% on Fraud Investigation